Showing results (2361-2370 of 9,156) with videos related to
Sort By:
Pageof 916
Cancer Medicine|January 11, 2016
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine modelsVasilios Liapis, Irene Zinonos, Agatha Labrinidis, et al.Cancer Medicine|January 15, 2016
Epithelial ovarian cancer subtypes attributable to smoking in the Norwegian Women and Cancer Study, 2012Idlir Licaj, Marko Lukic, Mie Jareid, et al.Cancer Medicine|January 26, 2016
A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2-positive early breast cancerErwin De Cock, Xavier Pivot, Nik Hauser, et al.Cancer Medicine|January 26, 2016
Late rectal toxicity determined by dose-volume parameters in computed tomography-based brachytherapy for locally advanced cervical cancerYong-Chun Zhou, Li-Na Zhao, Ning Wang, et al.Cancer Medicine|January 28, 2016
Pretreatment lymphopenia is an easily detectable predictive and prognostic marker in patients with metastatic esophagus squamous cell carcinoma receiving first-line chemotherapyFurong Kou, Zhihao Lu, Jian Li, et al.Cancer Medicine|January 29, 2016
The effects of hemoglobin levels and their interactions with cigarette smoking on survival in nasopharyngeal carcinoma patientsQi Zeng, Lu-Jun Shen, Sheng Li, et al.Cancer Medicine|January 29, 2016
PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcomaMio Hirahata, Mitsuhiko Osaki, Yusuke Kanda, et al.Cancer Medicine|December 22, 2015
Deletion/duplication mutation screening of TP53 gene in patients with transitional cell carcinoma of urinary bladder using multiplex ligation-dependent probe amplificationMohammad Reza R Bazrafshani, Pouriaali A Nowshadi, Sadegh Shirian, et al.Cancer Medicine|December 22, 2015
The clinicopathological significance of NAB2-STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumorsShih-Chiang Huang, Chien-Feng Li, Yu-Chien Kao, et al.Cancer Medicine|December 22, 2015
Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician surveyPeggy L Lin, Yanni Hao, Jipan Xie, et al.Pageof 916